This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Jean-Luc Dubois
Introduction
Jean-Luc Dubois is a notable inventor based in Vacquieres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that combat intestinal infections. His work is recognized for its impact on medical treatments and patient care.
Latest Patents
Jean-Luc Dubois holds a patent for a stable formulation containing fumagillin. This invention relates to a stable fumagillin formulation and the method of use thereof in treating and/or combating intestinal infections. His innovative approach has the potential to improve treatment outcomes for patients suffering from such infections.
Career Highlights
Jean-Luc Dubois is associated with Sanofi-Synthelabo, a leading global healthcare company. His role in the company has allowed him to contribute to important research and development projects. His expertise in pharmaceutical formulations has been instrumental in advancing the company's product offerings.
Collaborations
Jean-Luc Dubois has worked alongside Bernard Abramovici, a fellow innovator in the field. Their collaboration has fostered a productive environment for research and development, leading to advancements in pharmaceutical formulations.
Conclusion
Jean-Luc Dubois exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the formulation of fumagillin, highlight the importance of research in combating health challenges. His work continues to influence the field and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile